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Actinomycin synthesis by washed mycelia of Streptomyces antibioticus has been
conducted in the presence of 3-hydroxy-4-methylanthranilate-(carboxyl-l4C). In-
corporation of this compound into actinomycins has been observed, which consti-
tutes further evidence that 3-hydroxy-4-methylanthranilate is an intermediate in
actinomycin biosynthesis. The position of the incorporated label has been deter-
mined to be within the actinomycin chromophore, and the label appears to be equally
distributed between both halves of the chromophore. Incidental to these findings was
the observation that the "4C-labeled actinomycins were subject to rapid reabsorption
by the organism with actinomycin V taken up preferentially to actinomycin IV.
Brockmann and Muxfeldt (4) first described
the chemical synthesis of actinocin, the actino-
mycin chromophore, from 3-hydroxy-4-methyl-
anthranilic acid (MHA). On the basis of this and
other work, these investigators postulated that
MHA was an intermediate in actinomycin bio-
synthesis. The discovery by Katz and Weissbach
(12, 15, 22) of the enzyme phenoxazinone synthe-
tase in Streptomyces antibioticus, which catalyzes
the oxidative condensation of two molecules of
MHA (or MHA-pentapeptide) to form actinocin
(or an actinomycin), provided support for this
postulate. The latter workers and their collabo-
rators have also furnished other corroborating
evidence.
The incorporation of radioactivity from DL-
tryptophan-(benzene ring-14C) into actinomycin
by washed mycelia of S. antibioticus was inhibited
by MHA (23, 24). In this experiment the added
MHA appeared to trap radioactivity from the
tryptophan. If a product-precursor relationship
existed, this result was to be expected, since the
benzene ring of tryptophan had been established
as a precursor of actinocin (20). In addition, the
incorporation of 14C-L-valine into actinomycin
was stimulated by MHA (24). Both 3-hydroxy-
anthranilate and 3-hydroxykynurenine, each of
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which could be a precursor of MHA, mimicked
the effect ofMHA in the latter experiment. How-
ever, both of these compounds failed to dilute
incorporation of radioactivity from tryptophan-
(benzene ring-14C) into actinomycin.
Since firm evidence regarding the precursors of
the chromophore was desirable, we decided to
subject MHA to direct test as a precursor. For
this purpose we synthesized MHA-(carboxyl-14C)
chemically and incubated it with S. antibioticus.
MATERIALS AND METHODS
Materials. All reagents, unless otherwise specified,
were of reagent grade and were obtained from com-
mercial sources. 3-Methoxy-4-methylbenzoic acid and
2-nitro-3-hydroxy-4-methylbenzoic acid were pur-
chased from Aldrich Chemical Co., Milwaukee,
Wisc. Actinomycin IV (also named actinomycin D
and Dactinomycin) was generously provided by David
Hendlin of Merck, Sharp and Dohme Research
Laboratories. Prepoured thin-layer plates of Silica
Gel G, containing a fluorescent indicator, were ob-
tained from Brinkmann Instruments Inc., Westbury,
N.Y.
DL-Tryptophan-[benzene ring-'4C (UL) ] (3.81
c/mole) was a product of Nuclear-Chicago Corp.,
Des Plaines, Ill. '4C-cuprous cyanide (40 c/mole)
and "4C(UL)-L-valine (195 c/mole) and actinomycin
IV-(methyl-14C) (16 c/mole) were obtained from
New England Nuclear Corporation. Oxalic-1,2-'4C
acid (17.3 C/mole) was purchased from Tracerlab,
Waltham, Mass.
Organism. S. antibioticus (ATCC 14888; Rutgers
Institute of Microbiology Culture Collection no. 3720)
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was grown in soya peptone medium; actinomycin
synthesis was initiated by incubation of the organism
in glutamic acid-galactose medium by the method of
Goss and Katz (7). After 72 hr in this medium, the
mycelium was harvested by centrifugation, washed
with isotonic saline, and incubated at 28 C in a volume
of 0.1 M buffer (see Results) which was 40% that of
the original culture medium.
Incorporation experiments. Labeled compound was
added to the incubation mixture to give a concentra-
tion of 0.05 ,uc/ml. Samples of 5 ml each were taken
at indicated times and pipetted into 12-ml glass conical
centrifuge tubes packed in ice. The supernatant fluid
obtained on low-speed centrifugation was extracted
with ethyl acetate (13, 16). Both the unextracted
supernatant fluid and the neutral (pH 8.0) ethyl ace-
tate extract (containing the actinomycins) were
analyzed for radioactivity. Samples were counted in a
Nuclear-Chicago liquid scintillation spectrometer
with a naphthalene-dioxane scintillation system (1).
The neutral ethyl acetate fractions were chromato-
graphed on Silica Gel G thin-layer plates in the ethyl
acetate-acetone system (2:1) by the method of Katz,
Mauger, and Weissbach (9). The plates were assayed
for radioactivity by the method of Nishimura et al.
(17, 21) with a Nuclear-Chicago Actigraph III scanner
equipped with a thin-layer plate attachment and a
digital integrator.
Synthesis of MHA-[carboxyl-14C]. 3-Methoxy-4-
methylbenzoic acid was converted to 2-nitro-3-
methoxy-4-methylbenzoic acid by the procedure of
Simonsen and Rau (19). Conversion of this compound
to 2-nitro-3-methoxy-4-methyliodobenzene was ac-
complished essentially as described by Hankes (8).
This compound was treated with 14C-cuprous cyanide
to form the labeled nitrile. Hydrolysis of the cyano
function and removal of the methyl from the methoxy
group was accomplished by treatment in a sealed tube
with 6 N HCl at 110 C for 24 hr. This procedure did not
result in complete demethylation, but increased yields
of the desired product were obtained by repeated acid
treatment. 2-Nitro-3-hydroxy4-methylbenzoic-(car-
boxyl-14C)-acid was isolated from the reaction mix-
ture by thin-layer chromatography on Silica Gel G
plates with a solvent containing chloroform and acetic
acid (9:1). The radioactive compound cochromato-
graphed in this system with authentic compound.
MHA-(carboxyl-14C) was generated from this ma-
terial by reduction of the nitro group with sodium
dithionite by the method of Brockmann and Muxfeldt
(4). The product was purified by chromatography on a
column of Dowex-1 chloride by the procedure of
Weissbach et al. (24), and was used immediately for
the experiment.
Alkaline hydrogen peroxide oxidation of labeled
actinomycin: high voltage paper electrophoresis of the
product before and after acid hydrolysis. Actinomycin
was subjected to oxidation by alkaline hydrogen
peroxide by the procedure described by Bullock and
Johnson (5), but on a reduced scale. The labeled
sample (0.02 to 0.30 ,umole) was dissolved in 0.8 ml of
methanol and this solution was mixed with 1.0 ml of
alkaline hydrogen peroxide (3% H202; 0.75 N NaOH).
The reaction mixture was allowed to stand at room
temperature for 1 hr, after which time it was acidified
(turned Congo Red test paper blue) by the addition of
1 N HCl. The acidic solution was extracted three times
with 2-ml portions of ethyl acetate. The combined
ethyl acetate extracts were evaporated under reduced
pressure and the residue dissolved in a small volume
(ca. 0.3 ml) of methanol. Routinely, half of this solu-
tion was subjected to strong acid hydrolysis. For this
purpose, dried samples were mixed with 0.5 ml of 6
N HCl in small Pyrex tubes. The tubes were sealed
and placed in an oven at 105 C for 12 to 16 hr. The
contents of the tubes were then reduced to dryness
in vacuo at 30 C. Excess HCl was removed by re-
peated addition of water and by evaporation. The
residues were dissolved in water and spotted on What-
man 3MM strips (2.54 by 75 cm). The strips were
moistened with buffer [0.1 M tris(hydroxymethyl)-
aminomethane, 0.001 M disodium ethylenediamine-
tetraacetate (EDTA), adjusted to pH 7.4 by the addi-
tion of HCl] and subjected to electrophoresis in this
buffer at 40 v/cm for 1.5 hr in a Savant "flat-plate"
electrophoresis apparatus cooled to 0 C. Electropho-
resis of the unhydrolyzed product of the alkaline
hydrogen peroxide digest was carried out in the same
way. After electrophoresis the paper strips were dried
and counted on the Actigraph scanner. Radioactive
areas of the strips were eluted with water for further
analysis.
Identification of oxalate in acid hydrolysates of
alkaline hydrogen peroxide digests of 14C-MHA-
labeled actinomycin. Two criteria were used to estab-
lish the identity of "4C-labeled products of the com-
bined alkaline hydrogen peroxide and acid hydrolysis
treatment of actinomycin as oxalate: (i) comparison of
the migration of the product with that of authentic
14C-oxalate and (ii) precipitation of the product by
calcium ion as calcium oxalate. Aqueous eluates of
areas corresponding to oxalate on the paper electro-
phoresis strips were evaporated to dryness and mixed
with 0.30 ml of a 0.007 M solution of sodium oxalate.
Precipitation of the oxalate was effected by the addi-
tion of 0.70 ml of 0.1 M CaCI2. The resulting mixture
was heated in a boiling water bath for 2 to 3 min,
chilled in ice, and centrifuged. The supernatant fluid
was carefully removed by pipette and the precipitate
was washed with 1 ml of water. The washing was re-
peated once and the supernatant solutions combined.
The precipitate was dissolved by the addition of 1.0
ml of 0.12 M EDTA (adjusted to pH 9 with sodium
hydroxide). Samples of both the supernatant fraction
and the dissolved calcium oxalate precipitate were
assayed for radioactivity by scintillation counting as
described above.
RESULTS
Incorporation of '4C-L-valine into actinomycin
as a function of pH. The use of washed mycelia to
study the incorporation of "4C-labeled amino
acids into actinomycin has been reported by
Weissbach and co-workers (24). These workers
utilized 0.1 M potassium phosphate buffer at pH
7.3 for their incubations. Preliminary attempts to
test the incorporation of MHA into actinomycin
resulted in a small incorporation of the compound
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into product under these conditions. Analysis of
the incubation medium revealed that a large
quantity of the labeled substance had become
oxidized during the incubation. Since the aerobic
oxidation ofMHA is facilitated by higher pH, we
attempted to find conditions more suitable for
MHA by testing the incorporation of 14C-L-
valine into actinomycins by washed organisms in
0.1 M buffer at pH values from 5.40 to 7.45. In-
corporation of label under these conditions was
maximal at 30 min. When potassium phosphate
was used as buffer, a linear dependence of incor-
poration with pH was observed over the range
tested. The incorporation of the labeled amino
acid into actinomycins at pH 5.40 was 68% of
that observed at pH 7.45. The incorporation at
pH 6.05 was about 80% of that at pH 7.45; these
conditions were chosen for further experiments
with MHA.
Incorporation of 14C-MHA into actinomycin.
Addition of 14C-MHA to washed mycelia of S.
antibioticus in 0.1 M potassium phosphate at pH
6.05 resulted in a rapid uptake of 14C from the
medium, 70% of the label being taken up in 15
min and 82% of the label taken up in 2 hr. This
uptake is similar to that observed with L-amino
acid precursors of actinomycin, but it should be
noted that this is an apparent uptake by the or-
ganism. A significant portion of the medium
radioactivity is that which has in fact been taken
up by the organism and returned to the medium
in the form of actinomycin.
Analysis of the radioactivity in the medium was
performed as described above. In a control experi-
ment this procedure resulted in a high value for
ethyl acetate-extractable radioactivity (33% of
the total), a measure of the extractability of 14CG
MHA by this solvent at pH 6.05. Katz and Weiss-
bach (13) have shown that with labeled amino
acids, e.g., proline, valine, and threonine, neutral
ethyl acetate-extractable radioactivity is a measure
of actinomycin synthesis. In the 14C-MHA experi-
ments, therefore, it was necessary to purify the
neutral ethyl acetate extract further to ascertain
the amount of label in the actinomycins. This was
done by chromatography of the extract on Silica
Gel G thin-layer plates. A typical chromatogram
obtained with '4C-MHA-labeled actinomycins is
shown in Fig. 1. The positions of actinomycins
IV and V were verified by the location of yellow
bands on the thin-layer plates. These bands have
been shown to cochromatograph with authentic
actinomycins produced by S. antibioticus in this
system. Except for the relatively large amount of
radioactivity located at the origin, this chromato-
gram is quite similar to those obtained in experi-
ments in which actinomycins were labeled by
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FIG. 1. Thin-layer chromatography of 14C-MHA-
labeled actinomycin. The actinomycin fraction was
derivedfrom a 60-min incubation ofS. antibioticus with
14C-MHA and chromatographed on a Silica Gel G plate.
The plate was scanned in the Actigraph III at a scan rate
of30 cm/hr with a slit width of3 mm. Full scale deflec-
tion represents 500 counts/min.
radioactive amino acids. In addition, the results
obtained in this chromatographic system closely
parallel those seen in the circular paper chromato-
graphic system with the solvent system of 10%
sodium o-cresotinate n-dibutyl ether: symmetrical
tetrachloroethane at a ratio of 4:3:1 (11). Al-
though in the present study actinomycin mixtures
were not crystallized prior to chromatography,
there appears to be little doubt that the two major
components correspond to actinomycins V and
IV.
The peak at the origin of the chromatograms
did not correspond to a yellow band, indicating
that it was probably not associated with an
actinomycin. Moreover, it disappeared from the
medium with time, being almost absent at 2 hr.
The time course of the incorporation of 14C-
MHA into actinomycins (taken as the sum of
actinomycins IV and V on the plates) is sum-
marized in Table 1. Exact time points were diffi-
cult to obtain, particularly during the early part
of the experiment. This was due to the rapid up-
take of 14C-MHA by the organism, apparently
even during centrifugation in the cold. Incorpora-
tion of 14C-MHA appeared to reach a peak at
about 15 min after addition of the labeled com-
pound and then declined. Addition of L-trypto-
phan at a concentration of 0.1 mm resulted in a
20% decrease in incorporation at the peak,
whereas a 10-fold molar excess of unlabeled MHA
resulted in a 50% decrease in incorporation at the
peak and, surprisingly, almost no label in actino-
mycins by 2-hr. To explore this apparently anoma-
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TABLE 1. Incorporation of 14C-MHA into actinomycinsa
'4C in actinomycins (dpm/5 ml) at
Addition to incubation
Approx 2 min 15 min 30 min 60 min 120 min
None .................... 10,700 22,900 22,200 11,500 7,200
L-Tryptophan .............. 6,700 18,800 15,100 8,900 6,600
MHA 2,000 12,400 6,100 500 400
a14C-MHA (2.5 ,uc) was added to 50-ml incubation mixtures of S. antibioticus in 0.1 M potassium
phosphate buffer at pH 6.05. Incorporation into actinomycin was determined by chromatography of
the neutral ethyl acetate extract. Where indicated, L-tryptophan (5 /Amoles) or unlabeled MHA (0.6
,umole) was added.
lous result, an incorporation experiment was
conducted in which the ratio of '2C-L-valine to
4C-L-valine was increased from 0 to 220. The re-
sults presented in Fig. 2 indicate that there is in-
deed a linear relationship between this ratio and
the relative dilution of incorporation of '4C-L-va-
line into actinomycin. However, the nature of the
relationship is such that a 10-fold dilution of 14C-L-
valine is reflected in less than a 2-fold dilution of
label in actinomycin, a situation which is com-
pletely analogous to that observed with '4C-MHA.
These results are best explained by increased up-
take of amino acid or MHA at higher concentra-
tions. Incorporation values above those expected
from the dilution of labeled compound by the
unlabeled species actually indicate an increase in
20 50 100 IS0 too
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FIG. 2. The effect of addition of 12C-L-valine on
14C-L-valine incorporation into actinomycins. 14C-
L-valine (2.5 ,uc) were added to 50-ml incubation mix-
tures of washed cells of S. antibioticus in 0.1 M potas-
sium phosphate buffer at pH 6.05. Additions of 0 to
2500 nmoles of 12C-L-valine were made to each of six
incubations to make dilutions of the '4C-L-valine from
0- to 220-fold. After 30 min of incubation, the radio-
activity incorporated into actinomycin was determined.
The fold dilution of incorporation of 14C-L-valine into
actinomycin was calculated as the ratio of radioactivity
incorporated into actinomycin at no dilution to radio-
activity incorporated at the indicated dilution. The line
labeled "expected" would be obtained if the added 12C-
L-valine did not stimulate the incorporation of total
L-valine into actinomycin.
synthesis of actinomycins. For example, without
dilution, approximately 1.5 rnmoles of L-valine
was incorporated. Upon the addition of increas-
ing amounts of unlabeled amino acid, this value
rose linearly until it reached a maximum value of
9.6 nmoles incorporated, at approximately a 1 to
100 dilution of the "C-L-valine.
The disappearance of actinomycins in these
relatively short-term experiments was surprising.
One possibility that occurred to us was that the
actinomycins actually underwent degradation.
Since the degradation of actinomycin by the pro-
ducing species had not been previously described,
the authenticity of this observation was confirmed
by direct experiment. To this end, 0.25 ,uc of
actinomycin IV-(methyl-14C) was incubated with
washed organisms under conditions that were
completely analogous to those employed in the
incorporation experiments. Under these condi-
tions, the decline of neutral ethyl acetate-extract-
able material was linear for 30 min, by which
time 37% of the added actinomycin had been
degraded. Uptake of label from the medium into
the cells was also observed, but this reaction was
somewhat slower with 32% of the added label
taken up in 2 hr.
To gain further insight into the meaning of
these results, the formation of actinomycins IV
and V were studied separately with MHA as the
labeled compound (Table 2). Incorporation of
MHA into total actinomycin showed the same
pattern as that presented earlier. However, the
kinetics of incorporation of MHA into actino-
mycin IV differed markedly from that observed
for actinomycin V. For the first 30 min of the
incubation, actinomycin V was the predominant
labeled species present, after which time labeled
actinomycin IV was present in larger quantities.
Actinomycin V showed the rapid increase and
decline characteristic of the total actinomycin
fraction, whereas actinomycin IV appeared to be
a more stable species with a pattern similar to
those previously reported (14, 24). In preliminary
experiments to investigate this phenomenon, it
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TABLE 2. Incorporation of 14C-MHA into
separated actinomycinsa
14C in actinomycins (dpm/5 ml) at
Actinomycin
Approx
2 min
IV 1,500
V 2,200
a 14C-MHA (2.5,uc) was added to 50-ml incuba-
tions of S. antibioticus in 0.1 M potassium phos-
phate buffer at pH 6.05. Incorporation into actino-
mycins IV and V was determined by thin-layer
chromatography of the neutral ethyl acetate ex-
tracts of samples taken at the times indicated.
was found that solvent extraction of mycelium
harvested after incubation with 14C-MHA with
acetone or with chloroform-methanol by the
method of Folch et al. (6) released considerable
amounts of actinomycin. Analysis of this material
by thin-layer chromatography showed that the
major labeled component, as well as the major
unlabeled component, as judged by the intensity
of the yellow band on the plate, was actinomycin
V. It is conceivable that the virtually complete
disappearance by 60 min of the '4C-MHA-labeled
actinomycin in the experiment in which a 10-fold
excess of unlabeled MHA was added (Table 1)
was due to a preferential synthesis and reabsorp-
tion of actinomycin V by the organism under the
particular conditions of the experiment. Further
work bearing on this point is in progress.
Location of labeled carbons in actinomycin
abeled with 14C-MHA. It was important to deter-
mine the location of label incorporated into ac-
tinomycins, since the possibility existed that 14C-
MHA was first metabolized by the organism and
the labeled metabolites incorporated by indirect
and more or less random means into the anti-
biotic. If, on the other hand, the IC-MHA were
incorporated directly into actinomycins, the label
should have been located specifically in the car-
boxyl groups of the actinomycin chromophore.
Actinomycin was degraded in such a way as to
permit selection between the two alternatives.
This was accomplished by the alkaline peroxide
degradation of actinomycin by a modified method
of Bullock and Jonnson (5); the scheme for this
reaction is shown in Fig. 3. Actinomycin (com-
pound I), when treated with alkaline hydrogen
peroxide, is degraded into two major fractions
and unidentified components. The A peptide of
actinomycin is recovered after this treatment in
compound II which is 7-methylbenzoxazalone-4-
carboxyl pentapeptide A, whereas peptide B is
recovered as compound III which is oxalyl penta-
peptide B. Residues A and B may be the same
amino acid as in actinomycin IV where A =
B = L-proline (2, 3, 5, 14), or A and B may be
different amino acids as in actinomycin V where
one of these residues is L-proline and the other is
4-keto-L-proline.
When actinomycin IV labeled by 14C-MHA and
isolated by thin-layer chromatography was treated
with alkaline hydrogen peroxide and the reaction
mixture was analyzed by paper electrophoresis and
scanning of the paper for radioactivity, the pat-
tern shown in Fig. 4 (upper half) was obtained.
As expected, two major components were ob-
H3C CH3 H3C CH3 H3C CH3
CH CH CH
I II
CO-ClH(L) (L)CH-CO HOOC-CH(L)
NCH3 NCH3 NCH3
Sor Sar Sor
D-Vd H02D-lOMI
D-Val D-VaIDVa
I
o Co Co 0 HO - ° CO
I I I
CH3-CH-CH(L) (H-CH-CH3 CH3-CH-CH(L)I LiI
NH NH NHI I1- _I_
H3C CH3
CH
(L)CH-COOH
NCH3
I
Sar
D-Val
CO OH
(L}CH-CH-CH3
NH
*SO
COOH
(m)
J .0 UNIDENTIFIED(I) (EI) FRAGMENT(S)
FIG. 3. Alkaline hydrogen peroxide digestion of actinomycin. Symbols: Sar, sarcosine; D-Val, D-valine; aster-
isks, suspected positions of14C in actinomycin labeled by MHA-(carboxyl-14C).
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FiG. 4. Paper electrophoresis of alkaline hydrogen
peroxide digest of '4C-MHA-labeled actinomycin IV,
before and after acid hydrolysis. 14C-MHA-labeled
actinomycin IV (0.024,umole, 7,120 counts/min) was
subjected to alkaline H202 treatment and half of this
digest hydrolyzed in 6 N HCI. Both fractions (un-
hydrolyzed and hydrolyzed) were subjected to paper
electrophoresis at pH 7.4 and the electropherograms
scanned. The scan rate was 60 cm/hr with the slit
width at 12 mm. Full scale deflection in the scans repre-
sents 300 counts/min.
tained corresponding to compounds II and III in
approximately equal amounts. Strong acid hy-
drolysis of the unfractionated alkaline peroxide
reaction products gave an electrophoresis pattern
shown in the lower half of Fig. 4. Oxalate was
the major product recovered from this hydrolysis.
The absence of radioactivity near the origin of
the electrophoresis strip is significant since neutral
amino acids from the pentapeptide chains of
actinomycin would migrate to this position under
these conditions. Isolation of each of the com-
pounds produced by alkaline peroxide treatment
of actinomycin IV was accomplished by eluting
each of the two major peaks of radioactivity
seen in Fig. 4 (upper half). Acid hydrolysis per-
formed in these materials showed that only the
leading peak gave rise to oxalate. This allowed it
to be identified as compound III; the other peak
represents compound II. That compound II is
7-methylbenzoxazalone-4-carboxyl pentapeptide
has been verified by two procedures. First, when
this material was eluted from the paper and then
examined, it had spectral properties which were
the same as those described for it by Bullock and
Johnson (5). Secondly, the pentapeptide nature
of this compound was ascertained by the detec-
tion of all of the expected amino acids in acid
hydrolysates of the material. However, attempts
to obtain free 7-methylbenzoxazalone-4-carbox-
ylic acid by acid hydrolysis were not successful.
In fact, this substance appeared to be destroyed
upon acid hydrolysis, as assayed by the loss of its
characteristic spectrum. Precise localization of
the label was therefore not possible. However,
since electrophoretic analysis of the hydrolysates
clearly indicated that none of the radioactivity
was present in the amino acid residues, the con-
clusion can be made that the label must have
been in the 7-methylbenzoxazalone-4-carboxylic
acid residue.
Alkaline hydrogen peroxide degradations were
performed on actinomycin IV and actinomycin
V labeled writh 14C-MHA and with DL-trypto-
phan-[benzene ring-'4C (UL)]. The results of
these studies are presented in Table 3. If 14C_
MHA was equally distributed between both
halves of the molecule, 50% of the radioactivity
in actinomycin should be recoverable as labeled
TABLE 3. Alkaline hydrogen peroxide digestion of actinomycins IV and V labeled with "4C-MHA
and with DL-tryptophan- [benzene ring-14C( U) ]a
Actinomycin IV Actinomycin V
Description 1'4C-MHA | 4C-tryptophan 14C-MHA 14C-tryptophan
counts/ counts/ So counts/ counts/minl % min 0 min / min
Amount at start.7,030 (100) 105,000 (100) 8,370 (100) 61,400 (100)
Recovered from alkaline peroxide
digest. 6,480 92 50,200 48 7,200 86 41,000 67
Recovered from acid hydrolysis... 2,600 37 34,100 32 3,160 38 24,700 39
Recovered as oxalate.
.......1,16023 4,430 4.2 1,140 14 3,460 5.7
a Actinomycin IV (0.024 /Amole) and actinomycin V (0.038 ,umole) labeled with 14C-MHA and actino-
mycin IV (0.30 Mmole) and actinomycin V (0.19,Amole) labeled with DL-tryptophan-[benzene ring-'4C-(UL)] were subjected to alkaline hydrogen peroxide digestion. Oxalate was determined in 6 N HCl
hydrolysates of digests either by paper electrophoretic analysis at pH 7.4 or after precipitation with
calcium ion.
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oxalate. The lower-than-expected yields ob-
tained with actinomycins IV and V suggested
either that 14C-MHA was incorporated into
compound II preferentially, or that oxalate was
being lost during the hydrolysis. The latter hy-
pothesis was tested by subjecting 1.0 ,umole of
oxalic acid containing 0.1 ,c of authentic oxalic-
1,2-14C acid in the presence of 1 mg of actino-
mycin IV to hydrolysis with 6 N HCl at 105 C
for 15 hr. Analysis of the hydrolysate showed
that 54.5% of the oxalate was recoverable. Apply-
ing this value to the oxalate recovery data, the
theoretical recovery of oxalate from an actino-
mycin randomly labeled by 14C-MHA would be
26.8%, which is in good agreement with the
value obtained for actinomycin IV. The com-
paratively low yield of oxalate from actinomycin
V has not yet been satisfactorily explained. A
similar calculation for the theoretical yield of
oxalate from actinomycin randomly labeled with
DL-tryptophan-[benzene ring-'4C (UL)] would be
4.5%, which is in excellent agreement with the
values obtained for both actinomycins IV and V.
DISCUSSION
Mechanisms for actinomycin biosynthesis have
been proposed utilizing MHA or MHA-peptides
as intermediates on the basis of the known chem-
istry of MHA (2, 3). In these propositions MHA
is hypothesized as either first condensing to form
actinocin and then combining with peptide chains,
or by combining with the peptide chains first
and then condensing to form the complete ac-
tinomycin (24). The demonstration that ex-
ogenous MHA can be incorporated into actino-
mycin is a further indication that this compound
is an intermediate in actinomycin biosynthesis.
The question as to whether actinocin is an inter-
mediate in this process is not yet answered, but
preliminary results indicate that exogenous
actinocin is not incorporated into actinomycin
(unpublished data). Another question relates to
the role of the unidentified product of 14C-MHA
metabolism, which remained at the origin in
the thin-layer chromatography system. The slow
disappearance of this material, compared with
the rapid labeling and attainment of peak label-
ing of the actinomycin fraction, help to argue
against its participation in antibiotic synthesis.
Nevertheless, since this unknown material ap-
pears to undergo relatively rapid formation, its
identification may be important in ascertaining
alternate routes of MHA metabolism in the
organism.
The rapid decline of labeled actinomycin repre-
sents an interesting aspect of these results. Metab-
olism of actinomycin has been reported to be
accomplished by a species of Achromobacter (10)
and also by an Actinoplanes species which con-
tains an enzyme that hydrolyzes the lactone
bonds of the pentapeptide chains (18). However,
degradation of actinomycin by the producing
species has not been reported. Yoshida et al.
(25) observed that actinomycin could inhibit the
growth of the producing species when added to
growing organisms. Older organisms which were
producing the antibiotic were insensitive to
exogenous actinomycin. The authors speculate
that producing cells may develop a permeability
barrier to the antibiotic they are excreting. In
our experiments, antibiotic has been shown to be
degraded by washed mycelia of S. antibioticus.
The conversion of actinomycin IV-'4C to com-
pounds nonextractable with ethyl acetate is rapid,
and is consistent with observations made on
actinomycins synthesized from radioactive pre-
cursors such as "C-L-valine and 14C-MHA. In
addition, a slower reaction in which radioactivity
was removed from the medium was also observed.
This observation may be associated with the
finding that considerable quantities of actino-
mycin can be released from the organism by
organic solvent extraction, suggesting either
that the newly synthesized antibiotic is stored
intracellularly or that it may be reabsorbed by
the organism from the medium. When the sep-
arated actinomycins are compared, it is sig-
nificant that actinomycin V seems to disappear
selectively. The finding that the actinomycin in
the cells is primarily actinomycin V lends addi-
tional support to the hypothesis that this ac-
tinomycin may be selectively taken up into the
cells from the medium. Further investigation of
this phenomenon may yield new information
concerning the interrelationship of the actino-
mycins produced by S. antibioticus.
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